Phase 4
Completed N=22
Opioid Free Management After Ureteroscopy
Kidney Stone
Source: ClinicalTrials.gov NCT03872843 ↗
Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcomePrimary: Amount of Pain Medication Used — 7.3; 6.67 tablets
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this research study is to compare how well two medications work to control post-operative pain.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Amount of Pain Medication Used |
7.3; 6.67 | — |
| PRIMARY Number of Subjects Who Need Additional Pain Medication and/or Refill |
0; 0 | — |
| SECONDARY Urinary Index |
29.2; 22.3 | — |
Eligibility Criteria
Inclusion Criteria
- Ureteroscopy performed for renal stones
- Age over 18 years
- Two kidneys
Exclusion Criteria
- Solitary Kidney
- Poor kidney function (GFR<30)
- Allergy to either Ibuprofen or Norco
- Pelvic Kidney
Data sourced from ClinicalTrials.gov (NCT03872843). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.